Dominant ELOVL1 mutation causes neurological disorder with ichthyotic keratoderma, spasticity, hypomyelination and dysmorphic features
暂无分享,去创建一个
E. Obersztyn | R. Płoski | M. Rydzanicz | W. Nowak | J. Kosińska | A. Mika | T. Śledziński | A. Dziembowski | E. Jankowska-Steifer | C. Kowalewski | T. Kmieć | E. Jurkiewicz | A. Pollak | L. Korniszewski | A. Kutkowska-Kaźmierczak | A. Walczak | P. Gasperowicz | T. Stradomska | Aleksander Chlebowski | R. Jakubowski | Jakub Gruchota | D. Šladowski | Kamila Kłosowska-Kosicka | Adriana Mika
[1] J. Fischer,et al. Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment , 2017, American Journal of Clinical Dermatology.
[2] Xu Zheng,et al. Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Downregulates ELOVL1 Gene Expression and Fatty Acid Synthesis in Goat Fetal Fibroblasts , 2015, International journal of molecular sciences.
[3] R. Wanders,et al. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. , 2015, Biochimica et biophysica acta.
[4] F. Tempia,et al. ELOVL5 mutations cause spinocerebellar ataxia 38. , 2014, American journal of human genetics.
[5] E. Bertini,et al. Hypomyelinating leukodystrophies: Translational research progress and prospects , 2014, Annals of neurology.
[6] G. Rouleau,et al. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia. , 2014, JAMA neurology.
[7] P. Stepnowski,et al. Identification of Cyclopropaneoctanoic Acid 2-Hexyl in Human Adipose Tissue and Serum , 2013, Lipids.
[8] S. Itohara,et al. Impaired Epidermal Permeability Barrier in Mice Lacking Elovl1, the Gene Responsible for Very-Long-Chain Fatty Acid Production , 2013, Molecular and Cellular Biology.
[9] A. Kihara. Very long-chain fatty acids: elongation, physiology and related disorders. , 2012, Journal of biochemistry.
[10] S. Elledge,et al. SLIC: a method for sequence- and ligation-independent cloning. , 2012, Methods in molecular biology.
[11] F. Alkuraya,et al. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. , 2011, American journal of human genetics.
[12] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[13] Shota Suto,et al. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis , 2010, Proceedings of the National Academy of Sciences.
[14] R. Wanders,et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.
[15] J. Weissman,et al. A Molecular Caliper Mechanism for Determining Very Long-Chain Fatty Acid Length , 2007, Cell.
[16] B. Jayaprakasam,et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity Published, JLR Papers in Press, June 21, 2006. , 2006, Journal of Lipid Research.
[17] R. Westerberg,et al. Fatty acid elongases in mammals: their regulation and roles in metabolism. , 2006, Progress in lipid research.
[18] M. Metzker,et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy , 2001, Nature Genetics.
[19] P. Tvrdik,et al. Role of a New Mammalian Gene Family in the Biosynthesis of Very Long Chain Fatty Acids and Sphingolipids , 2000, The Journal of cell biology.